[1] OsolG,MandalaM., 2009.Maternal uterine vascular remodeling during pregnancy,Physiology 24 58 -71
[2] YoungBC,LevineRJ,KarumanchiSA, 2010.Pathogenesis of preeclampsia,Annu Rev Pathol Mech Dis 5 173 -92
[3] LevytskaK,DrewloS,BaczykD, 2014.regulates trophoblast differentiation in the BeWo cell model,PPAR Res 1 -13
[4] RuebnerM,LangbeinM,StrisselPL,HenkeC,SchmidtD,GoeckeTW, 2012.Regulation of the human endogenous retroviral syncytin-1 and cell-cell fusion by the nuclear hormone receptors PPAR/RXR in placentogenesis,J Cell Biochem 113 2383 -96
[5] McCarthyFP,DrewloS,EnglishFA,JohnsEJ,KennyLC,WalshSK, 2011.Evidence implicating peroxisome proliferatoractivated receptor- in the pathogenesis of preeclampsia,Hypertension 58 882 -7
[6] NossamanBD,KadowitzPJ, 2008.Potential benefits of peroxynitrite,Open Pharmacol J 2 31 -
[7] PellicerB,HerraizS,LealA,SimónC, 2011.Pellicer A. Prenatal brain damage in preeclamptic animal model induced by gestational nitric oxide synthase inhibition,J Pregnancy 1 -6
[8] McCarthyFP,DrewloS,JohnsEJ,WalshSK,KennyLC, 2011.Peroxisome proliferator-activated receptor- as a potential therapeutic target in the treatment of preeclampsia,Hypertension 58 882 -7
[9] WhitesallSE,HoffJB,VollmerAP,D'Alecy LG, 2004.Comparison of simultaneous measurement of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods,Am J Physiol Heart Circ Physiol 286 H2408 -H15
[10] BurtisCA,AshwoodER,BrunsDE, .Tietz textbook of clinical chemistry and molecular diagnostics,St Louis: Elsevier Health Sciences; 2012 679 -84
[11] LiL,FinkGD,WattsSW,NorthcottCA,GalliganJJ,PaganoPJ, 2003.Endothelin-1 increases vascular superoxide via endothelin A-NADPH oxidase pathway in low-renin hypertension,Circulation 107 1053 -8
[12] SinghR,SinghAK,AlaviN,LeeheyDJ, 2003.Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose,J Am Soc Nephrol 14 873 -80
[13] SunJ,ZhangX,BroderickM,Fein H, 2003.Measurement of nitric oxide production in biological systems by using Griess reaction assay,Sensors 3 276 -84
[14] CasartYC,TarrazziK,CamejoMI, 2007.Serum levels of interleukin-6, interleukin-1 and human chorionic gonadotropin in preeclamptic and normal pregnancy,Gynecol Endocrinol 23 300 -3
[15] TamKBT,GeorgeE,CockrellK,AranyM,SpeedJ,MartinJN, 2011.Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance,Am J Obstet Gynecol 204 e1 -e4
[16] GadHI, 2013.The potential role of anti tumor necrosis factor-alpha antibodies on some renal functions and vasoregulatory factors in preeclamptic pregnant Wistar rats,Saudi Med J 34 490 -6
[17] ZhouL,LiuG,JiaZ,YangKT,SunY,KakizoeY, 2013.Increased susceptibility of db/db mice to rosiglitazone-induced plasma volume expansion: role of dysregulation of renal water transporters,Am J Physiol Renal Physiol 305 F1491 -7
[18] SugawaraA,UrunoA,KudoM,MatsudaK,YangCW,ItoS., 2010.Effects of PPAR on hypertension, atherosclerosis, and chronic kidney disease,Endocrine J 57 847 -52
[19] ChodavarapuH,GrobeN,SomineniHK,SalemES,MadhuM,ElasedKM, 2013.Rosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion,PloS One 8 e62833 -
[20] ZaidOAA,Abdel-MaksoudH,ElmagidADA,AbdOM, 2014.Biochemical effect of preeclampsia on endothelin-1, interleukins and high sensitivity CRP,Benha Veterinary Med J 27 209 -16
[21] ValdésG,CorthornJ,BharadwajMS,JoynerJ,SchneiderD,BrosnihanKB, 2013.Utero-placental expression of angiotensin-(1-7) and ACE2 in the pregnant guinea-pig,Reprod Biol Endocrinol 11 5 -
[22] RenL,LiuN,ZhiH,LiY,LiY,TangR, 2011.Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro,Cardiovasc Diabetol 10 10 -
[23] BanksT,OyekanA, 2008.Peroxisome proliferator-activated receptor activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat,J Hypertens 26 468 -77
[24] XiaoJ,YinY,GaoY,LauS,ShenF,ZhaoM, 2012.The increased maternal serum levels of IL-6 are associated with the severity and onset of preeclampsia,Cytokine 60 856 -60
[25] DíazM,BassolsJ,López-BermejoA,Gómez-RoigMD,de ZegherF, 2012.Placental expression of peroxisome proliferator-activated receptor (PPAR): relation to placental and fetal growth,J Clin Endocrinol Metab 97 E1468 -72